Lifestyle Interventions to Reduce Diabetes Risk - Full Text View

Lifestyle Interventions to Reduce Diabetes Risk

This study has been completed.

Sponsored by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:	NCT00006162

Purpose

Type 2 diabetes is more frequent in Japanese Americans than in Japan or the U.S. non-Hispanic white population. This appears to be due to the effects of ''westernization'' to bring out metabolic changes that lead to diabetes. This study will look at whether increased physical activity and dietary changes will reduce or prevent the metabolic changes that lead to type 2 diabetes in Japanese Americans who have impaired glucose tolerance, a condition intermediate between normal glucose tolerance and diabetes.

Condition	Intervention
Glucose Intolerance Diabetes Mellitus, Type 2	Behavioral: exercise and diet

MedlinePlus related topics:

Diabetes Exercise and Physical Fitness

ChemIDplus related topics:

Dextrose

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Placebo Control

Official Title:	Interventions to Reduce Diabetic Risk in Japanese Americans

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Study Start Date:	October 1994
Estimated Study Completion Date:	April 1999

Eligibility

Ages Eligible for Study:	40 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Japanese American
Confirmed impaired glucose tolerance
Able to fill out questionnaires

Exclusion Criteria:

Significant exercise-restricting disease
Poorly controlled hypertension
Psychiatric disease or dementia
Already on unusually restrictive diet
Use of hypolipidemic drugs
Use of tobacco
Abnormal blood screening tests
ECG evidence of ischemic heart disease at rest
Abnormal maximal Bruce treadmill test

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006162

Locations


United States, Washington
	University of Washington
	Seattle, Washington, United States, 98195

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

Study ID Numbers:	fujimotow, 1R01DK48152
First Received:	August 8, 2000
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00006162
Health Authority:	United States: Federal Government